Epilepsy Drug Sulthiame Shows Promise Against Obstructive Sleep Apnoea
Significant Findings on Sulthiame and Sleep Apnoea
Recent research conducted by Swedish professionals reveals exciting potential for the epilepsy drug Sulthiame in treating obstructive sleep apnoea. The study indicates that patients using Sulthiame experienced an astounding 40% reduction in symptoms when compared to those administered a placebo.
Exploring the Implications
This discovery prompts further investigation into how medications designed for epilepsy might also alleviate symptoms of severe sleep disorders. It opens new avenues for treating complications associated with sleep apnoea that affects millions worldwide.
- Sulthiame as an anti-epileptic drug
- Potential for patient repurposing
- Impact on nocturnal breathing
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.